GM2: Clinical Sequencing at University of Washington - Gail Jarvik
Jarvik
Dr. Gail Jarvik - July 6, 2016
GM2: Summary of Genomic Medicine I meeting in Chicago - Geoff Ginsburg
GM2: Clinically Actionable Variants Meeting Summary - Marc Williams
GM2: CLIA approved sequencing, GENEINSIGHT - Scott Weiss
Discussion: Implementing Genomic Sequencing in the Clinical Setting - Les Biesecker and Gail Jarvik
Introductions: Gail Jarvik and Les Biesecker - Rudy Pozzatti
GM2: Genomic Medicine Programs at the NIH Clinical Center - Bill Gahl and Les Biesecker
Consent, Data Access, Ability to Recontact - Gail Jarvik
Challenges and opportunities with clinical exome sequencing
GM2: Pharmacogenomics - Howard McLeod
Interpreting Variants / Actionability (Challenges/Opportunities) - Gail Jarvik
FDA’s Jennifer Dickey Provides a Regulatory Review of Clinical Sequencing Assays
Orthopaedics and Sports Medicine - June 4th, 2014 - Orthopaedics and Palliative Medicine
Evidence Generation for Genomic Medicine (eMERGE) - Gail Jarvik
Clinical Next Generation Sequencing (NGS)
CLIA Diagnostics Laboratory
Genomic Medicine XI Debate: Role of primary care providers in genomic medicine
High-throughput Sequencing in Trauma Infections: Towards Microbiology 2.0
